This study evaluates the predictive power of multi-parametric MRI at pre-therapy and mid-RT time points in predicting progression-free and overall survival of patients with glioblastoma (GBM). We trained and tested random forest models using metabolic, perfusion, and diffusion images at both preRT and midRT scans, and found that not confining these metrics to the anatomical lesion boundaries improved outcome prediction. The CEL volume mid-RT and type of treatment were among the most important features in predicting PFS, while the T2L volume and metabolic metrics at pre-RT were more relevant for OS prediction.
This abstract and the presentation materials are available to members only; a login is required.